EORTC protocol 22932

Phase III randomized study on the role of the booster dose of postoperative radiotherapy in patients with early stage carcinomas of head and neck (Jointly with the EORTC Radiotherapy Cooperative Group)
Trial StatusAll trial activities ended
DatesDate of activation: 09-Feb-94
Closed on : 20-Nov-95
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size408
Number of steps1
Drug
Study StaffJacques Bernier (Study Coordinator) - Clinique De Genolier, Genolier
Francesco Cognetti (Study Coordinator) - Istituto Regina Elena, Roma
Jean-Louis Lefebvre (Study Coordinator) - Centre Oscar Lambret, Lille
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section